MétaCan
Menu
Back to cohort
Record W2113865865 · doi:10.1186/s13058-014-0474-y

Refined histopathological predictors of BRCA1 and BRCA2mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia

2014· article· en· W2113865865 on OpenAlexafffund
Amanda B. Spurdle, Fergus J. Couch, Michael T. Parsons, Lesley McGuffog, Daniel Barrowdale, Manjeet K. Bolla, Qin Wang, Sue Healey, Rita K. Schmutzler, Barbara Wappenschmidt, Kerstin Rhiem, Christoph Engel, Alfons Meindl, Nina Ditsch, Norbert Arnold, Hansjoerg Plendl, Dieter Niederacher, Christian Sutter, Shan Wang‐Gohrke, Doris Steinemann, Sabine Preisler-Adams, Karin Kast, Raymonda Varon-Mateeva, Debra Frost, Radka Platte, Jo Perkins, D. Gareth Evans, Louise Izatt, Rosalind A. Eeles, Julian Adlard, Rosemarie Davidson, Trevor Cole, Giulietta Scuvera, Siranoush Manoukian, Bernardo Bonanni, Frédérique Mariette, Stefano Fortuzzi, Alessandra Viel, Barbara Pasini, Laura Papi, Liliana Varesco, Rosemary L. Balleine, Katherine L. Nathanson, Susan M. Domchek, Kenneth Offitt, Anna Jakubowska, Noralane M. Lindor, Mads Thomassen, Uffe Birk Jensen, Johanna Rantala, Åke Borg, Irene L. Andrulis, Alexander Miron, Thomas van Overeem Hansen, Trinidad Caldés, Susan L. Neuhausen, Amanda E. Toland, Heli Nevanlinna, Marco Montagna, Judy Garber, Andrew K. Godwin, Ana Osório, Rachel E. Factor, Mary Beth Terry, Timothy R. Rebbeck, Beth Y. Karlan, Melissa C. Southey, Muhammad Usman Rashid, Nadine Tung, Paul D.P. Pharoah, Fiona M. Blows, Alison M. Dunning, Elena Provenzano, Per Hall, Kamila Czene, Marjanka K. Schmidt, Annegien Broeks, Sten Cornelissen, Senno Verhoef, Peter A. Fasching, Matthias W. Beckmann, Arif B. Ekici, Dennis J. Slamon, Stig E. Bojesen, Børge G. Nordestgaard, Sune F. Nielsen, Henrik Flyger, Jenny Chang‐Claude, Dieter Flesch‐Janys, Anja Rudolph, Petra Seibold, Kristiina Aittomäki, Taru Muranen, Päivi Heikkilä, Carl Blomqvist, Jonine D. Figueroa, Stephen J. Chanock, Louise A. Brinton, Jolanta Lissowska, Janet E. Olson, V. Shane Pankratz, Esther M. John, Alice S. Whittemore, Dee W. West, Ute Hamann, Diana Torres, Hans Ulrich Ulmer, Thomas Rüdiger, Peter Devilee, Robert A.E.M. Tollenaar, Caroline Seynaeve, Christi J. van Asperen, William Tapper, Lorraine Durcan, J. Louise Jones, Julian Peto, Isabel dos‐Santos‐Silva, Olivia Fletcher, Nichola Johnson, Miriam Dwek, Ruth Swann, Anita Bane, Gord Glendon, Anna Marie Mulligan, Graham G. Giles, Roger L. Milne, Laura Baglietto, Catriona McLean, Jane Carpenter, Christine L. Clarke, Rodney J. Scott, Hiltrud Brauch, Thomas Brüning, Yon‐Dschun Ko, Angela Cox, Simon S. Cross, Malcolm Reed, Jan Lubiński, Katarzyna Jaworska–Bieniek, Katarzyna Durda, Jacek Gronwald, Thilo Dörk, Natalia Bogdanova, Tjoung‐Won Park‐Simon, Peter Hillemanns, Christopher A. Haiman, Brian E. Henderson, Fredrick R. Schumacher, Loı̈c Le Marchand, Barbara Burwinkel, Frederik Marmé, Harald Surovy, Rongxi Yang, Hoda Anton‐Culver, Argyrios Ziogas, Maartje J. Hooning, J. Margriet Collée, John W.M. Martens, Madeleine M.A. Tilanus‐Linthorst, Hermann Brenner, Aida Karina Dieffenbach, V Arndt, Christa Stegmaier, Robert Winqvist, Katri Pylkäs, Arja Jukkola‐Vuorinen, Mervi Grip, Annika Lindblom, Sara Margolin, Joseph Vijai, Mark E. Robson, Rohini Rau‐Murthy, Anna González‐Neira, José Ignacio Arias, Pilar Zamora, Javier Benı́tez, Vesa Kataja, Veli-Matti Kosma, Jaana M. Hartikainen, Paolo Peterlongo, Daniela Zaffaroni, Monica Barile, F Capra, Paolo Radice, Soo‐Hwang Teo, Douglas F. Easton, Antonis C. Antoniou, Georgia Chenevix‐Trench, David E. Goldgar

Bibliographic record

VenueBreast Cancer Research · 2014
Typearticle
Languageen
FieldBiochemistry, Genetics and Molecular Biology
TopicBRCA gene mutations in cancer
Canadian institutionsJuravinski HospitalMcMaster University Medical CentreCanada Research ChairsUniversity Health NetworkUniversity of New BrunswickUniversity of TorontoMount Sinai HospitalLunenfeld-Tanenbaum Research Institute
FundersUniversitätsklinikum Hamburg-EppendorfInstituto de Salud Carlos IIICancer Council VictoriaMedical Research CouncilCanadian Institutes of Health ResearchSchool of MedicineU.S. Department of DefenseCancer Research UKUniversität UlmNational Health and Medical Research CouncilUniversiti MalayaOulun YliopistoDeutsche KrebshilfeMedizinischen Hochschule HannoverKuopion Yliopistollinen SairaalaKarolinska InstitutetBundesministerium für Bildung und ForschungMinisterio de Economía y CompetitividadDeutsche Gesetzliche UnfallversicherungNederlandse Organisatie voor Wetenschappelijk OnderzoekKommunfullmäktige, Stockholms StadMinistero della SaluteAcademy of FinlandRobert Bosch StiftungCancer Research InstituteAgency for Science, Technology and ResearchNational Breast Cancer FoundationCancer Center, University of KansasCancerfondenFundación Mutua MadrileñaNational Cancer InstituteCancer Institute NSWBreast Cancer CampaignNational Institute for Health and Care ResearchKWF KankerbestrijdingPeter MacCallum Cancer CentreHerlev HospitalNational Institutes of HealthDavid F. and Margaret T. Grohne Family FoundationUniversity of WestminsterDeutsches KrebsforschungszentrumKansas Bioscience AuthoritySundhed og Sygdom, Det Frie ForskningsrådAssociazione Italiana per la Ricerca sul CancroItä-Suomen YliopistoHelsingin ja Uudenmaan SairaanhoitopiiriFox Chase Cancer CenterEberhard Karls Universität TübingenMemorial Sloan-Kettering Cancer CenterSusan G. Komen for the CureRheinische Friedrich-Wilhelms-Universität BonnBeth Israel Deaconess Medical CenterRoyal Marsden NHS Foundation TrustHuntsman Cancer InstituteMayo ClinicBreast Cancer Research Foundation
KeywordsSurgical oncologyBreast cancerMedicineOncologyInternal medicineScale (ratio)Cancer

Abstract

fetched live from OpenAlex

INTRODUCTION: The distribution of histopathological features of invasive breast tumors in BRCA1 or BRCA2 germline mutation carriers differs from that of individuals with no known mutation. Histopathological features thus have utility for mutation prediction, including statistical modeling to assess pathogenicity of BRCA1 or BRCA2 variants of uncertain clinical significance. We analyzed large pathology datasets accrued by the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA) and the Breast Cancer Association Consortium (BCAC) to reassess histopathological predictors of BRCA1 and BRCA2 mutation status, and provide robust likelihood ratio (LR) estimates for statistical modeling. METHODS: Selection criteria for study/center inclusion were estrogen receptor (ER) status or grade data available for invasive breast cancer diagnosed younger than 70 years. The dataset included 4,477 BRCA1 mutation carriers, 2,565 BRCA2 mutation carriers, and 47,565 BCAC breast cancer cases. Country-stratified estimates of the likelihood of mutation status by histopathological markers were derived using a Mantel-Haenszel approach. RESULTS: ER-positive phenotype negatively predicted BRCA1 mutation status, irrespective of grade (LRs from 0.08 to 0.90). ER-negative grade 3 histopathology was more predictive of positive BRCA1 mutation status in women 50 years or older (LR = 4.13 (3.70 to 4.62)) versus younger than 50 years (LR = 3.16 (2.96 to 3.37)). For BRCA2, ER-positive grade 3 phenotype modestly predicted positive mutation status irrespective of age (LR = 1.7-fold), whereas ER-negative grade 3 features modestly predicted positive mutation status at 50 years or older (LR = 1.54 (1.27 to 1.88)). Triple-negative tumor status was highly predictive of BRCA1 mutation status for women younger than 50 years (LR = 3.73 (3.43 to 4.05)) and 50 years or older (LR = 4.41 (3.86 to 5.04)), and modestly predictive of positive BRCA2 mutation status in women 50 years or older (LR = 1.79 (1.42 to 2.24)). CONCLUSIONS: These results refine likelihood-ratio estimates for predicting BRCA1 and BRCA2 mutation status by using commonly measured histopathological features. Age at diagnosis is an important variable for most analyses, and grade is more informative than ER status for BRCA2 mutation carrier prediction. The estimates will improve BRCA1 and BRCA2 variant classification and inform patient mutation testing and clinical management.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.009
metaresearch head score (Gemma)0.021
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.018
Threshold uncertainty score0.048

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0090.021
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0010.001
Bibliometrics0.0040.006
Science and technology studies0.0010.001
Scholarly communication0.0020.001
Open science0.0010.003
Research integrity0.0010.001
Insufficient payload (model declined to judge)0.0020.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.019
GPT teacher head0.325
Teacher spread0.306 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations122
Published2014
Admission routes2
Has abstractyes

Explore more

Same venueBreast Cancer ResearchSame topicBRCA gene mutations in cancerFrench-language works237,207